Logo
ScienceStack
Table of Contents
Fetching ...
Sign In

A mathematical perspective on the paradox that chemotherapy sometimes works backwards

Luis A. Fernández, Isabel Lasheras, Cecilia Pola

TL;DR

The paper addresses the paradox that chemotherapy can sometimes promote tumor growth by analyzing a minimal tumor–vasculature model with Gompertz tumor dynamics and vascular carrying capacity. Using the Hahnfeldt framework augmented by Norton–Simon cytotoxic effects and antiangiogenic influences, it identifies parameter regimes where high drug concentrations destabilize the system, yielding paradoxical growth, as well as regimes where tumors shrink or stabilize. It introduces a clear normal/abnormal dichotomy based on long-term behavior and demonstrates that the abnormal regime expands with cytotoxic intensity but can be avoided by delaying treatment or preconditioning the vasculature through antiangiogenic priming. The work further extends to time-dependent drug effects with PK considerations, showing that metronomic and sequenced antiangiogenic/cytotoxic strategies are robust and effective under realistic dosing scenarios, providing quantitative guidance for improving treatment planning and reducing paradoxical responses.

Abstract

Doctors are well aware that sometimes cancer treatments not only fail, but even work backwards, i.e. they make the treated tumor grow. In this work we present a mathematical perspective on this paradox in the case of chemotherapy, by studying a minimally parameterized mathematical model for the system composed of the tumor and the surrounding vasculature. To this end, we will use a system of two well-established nonlinear ordinary differential equations, which incorporates the cytotoxic (via the Norton-Simon hypothesis) and antiangiogenic effects of chemotherapy. Finally, we provide two theoretical ways to avoid these anomalies.

A mathematical perspective on the paradox that chemotherapy sometimes works backwards

TL;DR

The paper addresses the paradox that chemotherapy can sometimes promote tumor growth by analyzing a minimal tumor–vasculature model with Gompertz tumor dynamics and vascular carrying capacity. Using the Hahnfeldt framework augmented by Norton–Simon cytotoxic effects and antiangiogenic influences, it identifies parameter regimes where high drug concentrations destabilize the system, yielding paradoxical growth, as well as regimes where tumors shrink or stabilize. It introduces a clear normal/abnormal dichotomy based on long-term behavior and demonstrates that the abnormal regime expands with cytotoxic intensity but can be avoided by delaying treatment or preconditioning the vasculature through antiangiogenic priming. The work further extends to time-dependent drug effects with PK considerations, showing that metronomic and sequenced antiangiogenic/cytotoxic strategies are robust and effective under realistic dosing scenarios, providing quantitative guidance for improving treatment planning and reducing paradoxical responses.

Abstract

Doctors are well aware that sometimes cancer treatments not only fail, but even work backwards, i.e. they make the treated tumor grow. In this work we present a mathematical perspective on this paradox in the case of chemotherapy, by studying a minimally parameterized mathematical model for the system composed of the tumor and the surrounding vasculature. To this end, we will use a system of two well-established nonlinear ordinary differential equations, which incorporates the cytotoxic (via the Norton-Simon hypothesis) and antiangiogenic effects of chemotherapy. Finally, we provide two theoretical ways to avoid these anomalies.

Paper Structure

This paper contains 5 sections, 4 theorems, 27 equations, 5 figures, 8 tables.

Table of Contents

  1. Pharmacodynamics
  2. Constant drug effects
  3. Piecewise constant drug effects
  4. Time-dependent drug effects
  5. Conclusions

Key Result

Theorem 1

Let us assume that $\lambda_1, b, d \in \mathbb{R}^+$ and $\lambda_2 \in \mathbb{R}^+_0$. Given any initial condition $(V_0,K_0) \in (\mathbb{R}^+)^2,$ the Cauchy problem (EVK) has a unique solution $(V,K) \in (C^\infty(\mathbb{R}^+_0))^2$. Moreover, $(V(t),K(t)) \in (\mathbb{R}^+)^2$ for each $t \i

Figures (5)

  • Figure 1: Trajectories for $\lambda_1>0$, $b > \lambda_2$ and $b \leq \lambda_2$ in the left and right graphs, respectively. The parameter values are those of Table \ref{['tablaparametros1']} except that for the right one, $\lambda_2=1.7$.
  • Figure 3: Initial points leading to $V(t) \longrightarrow 0$ in cyan and those for which $V(t) \longrightarrow +\infty$ in red. The parameter values are those of Table \ref{['tablaparametros1']} with $E_a=0$.
  • Figure 7: Trajectories with data from the second case of Table \ref{['tablaresultados2']} except that for the one on the left, $\lambda_2=1.7$. The initial points are $(P_1)$ and $(P_2)$ on the left and right graphs, respectively.
  • Figure 8: Results with cytotoxic discrete treatments (in black) and constant effect treatment (in magenta) of Table \ref{['tablaresultados1']} for the initial point $(P_1)$ on the left and $(P_2)$ on the right.
  • Figure 9: Results with cytotoxic discrete treatments with three-day delay (in black) of Table \ref{['tablaresultados2']} for the initial point $(P_1)$ on the left and $(P_2)$ on the right.

Theorems & Definitions (9)

  • Theorem 1
  • proof
  • Theorem 2
  • proof
  • Remark 1
  • Theorem 3
  • proof
  • Proposition 1
  • proof